GNI Group Co., Ltd. privacy policy Terms of use site map Employment information English top page About GNI Group R & D (R & D) IR (Investor Relations) Contact Us Latest information Latest information list July 06, 2015 Notice Our report by Macquarie Securities has been published in Bloomberg for Business. June 12, 2015 Notice Our article was published on the daily pharmaceutical industry WEB. IR information IR information list About GNI Group Representative message Business model / business overview List of officers Company profile / group structure List of offices Corporate governance R & D (R & D) R & D (R & D) Product pipeline Aisuryui (Chinese: moxa思瑞® ) F351 F573 Tamibarotene Disease research area Lung disease Liver disease Kidney disease Research publications IR (Investor Relations) IR (Investor Relations) IR news Financial information Information session / convocation notice TSE filing Electronic public notice Representative message Business model / business overview Stock price information To the top of this page top page About GNI Group R & D (R & D) IR (Investor Relations) Contact Us news release privacy policy Terms of use site map Employment information © GNI LTD. All Rights Reserved.